Clinical Trial Update: Estimates of the Short-term Efficacy of Talineuren (TLN) and Placebo in Patients With Parkinson Disease [Phase 2]

View source ↗

Summary

This clinical trial update reports short-term efficacy estimates for Talineuren (TLN) versus placebo in Parkinson's disease in a Phase 2 study that is not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Talineuren (TLN) (Talineuren)

Snippet

Sponsor: InnoMedica Schweiz AG | Conditions: Parkinson Disease | Phase 2 | Status: NOT_YET_RECRUITING